BOBBI PORCHE: Open Payments
NPI 1417453630 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 30 payments from 7 companies in 2025. Trend: 2023 $185 · 2024 $263 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $184 |
| ABBVIE INC. | 9 | $175 |
| Axsome Therapeutics, Inc. | 5 | $108 |
| Janssen Pharmaceuticals, Inc | 3 | $91 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $14 |
Products named: REXULTI, VRAYLAR, Auvelity, SPRAVATO, AUSTEDO XR, INGREZZA, ABILIFY MAINTENA.
Industry payments across TX — which companies pay providers there.
